Price
$36.00+14.14%Social Signal Score
Analyst Ratings
17 analystsRevenue
$673.24M+42.44%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Caroline Sullivan Grace
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 2,664
- Beta
- 0.39
- Country
- US
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 3.07
Financials
Revenue
$673.24M+42.4%Net Income
$21.16M-22.5%EBITDA
$58.49M+7.4%Free Cash Flow
$-198.46M-902.6%EPS (diluted)
$0.53-3.6%Shares Outstanding (diluted)
39.73M-19.6%Operating Expenses
$147.39MCash & Debt
$361.84MReturn of Capital
$2.25MRevenue by Segment (annual)
$611.77MDividend per Share
$0.30Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.73B | $-95.70M | $-2.48 |
| 2024 | $2.98B | $-146.98M | $-3.85 |
| 2023 | $3.79B | $210.68M | $5.38 |
| 2022 | $5.24B | $444.05M | $9.96 |
| 2021 | $3.98B | $327.39M | $6.87 |
| 2020 | $2.39B | $70.67M | $1.49 |
| 2019 | $2.22B | $113.99M | $2.44 |
| 2018 | $2.14B | $141.74M | $2.99 |
| 2017 | $1.99B | $132.56M | $2.77 |
| 2016 | $1.90B | $105.84M | $2.21 |
| 2015 | $1.46B | $81.89M | $1.72 |
| 2014 | $1.04B | $33.22M | $0.71 |
| 2013 | $1.01B | $32.93M | $0.72 |
| 2012 | $953.95M | $17.14M | $0.38 |
Valuation
AMNhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120+0.00%Social Signal Score
Mentions (6)
- Newszacks.com·12d ago·Positive
Here's Why AMN Healthcare Services (AMN) is a Strong Momentum Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newszacks.com·27d ago·Neutral
Here's Why You Should Retain AMN Stock in Your Portfolio for Now AMN Healthcare is poised for growth as staffing demand rebounds, MSP penetration expands and tech-enabled workforce solutions broaden its reach.
View source ↗ - Newszacks.com·41d ago·Positive
Here's Why AMN Healthcare Services (AMN) is a Strong Momentum Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newszacks.com·42d ago·Neutral
AMN Stock Rallies Nearly 119% YTD: What's Behind the Momentum? AMN Healthcare's 2026 surge is backed by rebounding nurse and allied demand, stronger execution and persistent healthcare workforce shortages.
View source ↗ - Newszacks.com·55d ago·Neutral
5 Broker-Loved Stocks to Watch as September Rate Hike Seems Unlikely Weak July jobs data dims September rate-hike odds, putting broker-favored stocks like Avnet, RXO, Forward Air, Air Canada and AMN Healthcare in focus.
View source ↗ - Newsmarketbeat.com·59d ago·Positive
AMN Healthcare Services Q2 Earnings Call Highlights AMN Healthcare Services NYSE: AMN reported second-quarter results above its guidance range, aided by stronger demand in travel nursing, allied staffing and search services, as well as labor disruption-related revenue and several favorable reserve items.
View source ↗
Earnings
Thu, Nov 5(in 4 weeks)
Consensus estimate $0.23 per share
Typical surprise +76.5% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$0.77 vs $0.19beat
- Thu, May 7$2.10 vs $1.60beat
- Thu, Feb 19$0.22 vs $0.22beat
- Thu, Nov 6$0.39 vs $0.19beat
- Thu, Aug 7$0.30 vs $0.17beat
- Thu, May 8$0.45 vs $0.19beat
Estimates and results for AMN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by AMN officers and directors.
- Bought
- —
- Sold
- $114k
0 trades
2 trades
- Foletta Mark Gsold
- Foletta Mark Gsold
98 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Greg Gianfortehouse · MT00 · disclosed Dec 2, 2020 (23d later)Buy$15,001 - $50,000
- Greg Gianfortehouse · MT00 · disclosed Sep 15, 2020 (13d later)Buy$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Sep 15, 2020 (15d later)Buy$15,001 - $50,000
- Greg Gianfortehouse · MT00 · disclosed Jul 27, 2020 (5d later)Buy$50,001 - $100,000
- Greg Gianfortehouse · MT00 · disclosed Nov 27, 2019 (47d later)Buy$100,001 - $250,000
- Greg Gianfortehouse · MT00 · disclosed Oct 20, 2019 (40d later)Sell$100,001 - $250,000
- Greg Gianfortehouse · MT00 · disclosed Mar 6, 2019 (41d later)Buy$100,001 - $250,000
- Greg Gianfortehouse · MT00 · disclosed Feb 2, 2019 (40d later)Sell$100,001 - $250,000
- Thomas Charles MacArthurhouse · NJ03 · disclosed Jul 10, 2018 (33d later)Buy$15,001 - $50,000
- Greg Gianfortehouse · MT00 · disclosed Jun 15, 2018 (8d later)Buy$100,001 - $250,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.